sepsis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1:Patients with sepsis due to pneumonia (including septic shock) and with an acute DIC criteria of at least 4 points. 2:Age is 20 years or older at the time of case registration. 3:AT activity level less than 70%. 4:Written informed consent has been obtained from the study subjects themselves or their surrogates.
Exclusion criteria
Exclusion criteria: 1:Patients with any of the following. (i) Complicated non-compensated liver cirrhosis with a Child-Pugh score of Grade B or above. (ii) Leukemia and related diseases. (iii) Patients with malignant tumors and receiving chemotherapy 2:Acute stage of trauma and burn injury 3:Patients receiving concomitant use of recombinant thrombomodulin 4:Patients on hemodialysis or extracorporeal circulation (CHDF, ECMO) 5:Research subjects who are judged by the principal investigator or physician in charge to be unsuitable for the safe conduct of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Transition in coagulation fibrinolysis markers, inflammatory cytokines, vascular endothelial markers and AT during the first 5 days after administration of AT preparations | — |
Countries
Japan
Contacts
Osaka Medical and Pharmaceutical University Department of Emergency and Critical Care Medicine